Ensysce Biosciences Is A Clinical Stage Pharmaceutical Company Dedicated To Enhancing Medication Safety Through Innovative Oral Drug Delivery Technologiesthe Company Specializes In Developing Abuse Deterrent And Overdose Resistant Pharmaceuticalsparticularly Aimed At Addressing Challenges In Pain Management And Substance Use Disordersensysce Utilizes Proprietary Technologiesincluding Taapa Ctrypsin Activated Abuse Protectionand Mpara Multi Pill Abuse Resistance To Create Safer Therapeutics That Improve Patient Outcomes While Reducing The Risks Of Drug Abuse The Company S Product Pipeline Includes Pf614A Taap Modified Oxycodone Prodrug For Pain Managementand Taap Based Amphetamine Prodrugs Targeting Prescription Stimulant Abuseensysce Also Focuses On Developing Abuse Deterrent Formulations For Opioid Use Disorder Treatmentin Addition To Its Drug Development Effortsensysce Offers Clinical And Preclinical Development Servicesproprietary Technology Licensingand Drug Delivery Innovation To Partners In The Healthcare And Pharmaceutical Sectorsthe Company Is Committed To Leading The Market In Abuse Deterrent Pharmaceuticals And Addressing Critical Public Health Needs
